HSIC — Henry Schein, Inc. stock price, charts and financials

QT62Henry Schein, Inc.

Henry Schein, Inc. (NASDAQ: HSIC) is a Healthcare company in the Medical - Distribution industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
89.11
+2.60+3.01%
HSICQT62Henry Schein, Inc.·NASDAQ
89.11+3.01%
Filing
Up 3.0% — Filed an 8-K material-event report (2026-08-04) — details in the filing.
Medium confidence
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E26.92EPS (ttm)3.31Insider Own5.55%Shs Outstand113.92MPerf Week3.97%
Market Cap10.15BForward P/E15.08EPS next Y5.91Insider Trans-1.52%Shs Float93.88MPerf Month2.87%
Enterprise Value13.68BPEG3.43EPS next Q-Inst Own-Short Float6.96%Perf Quarter23.73%
Income395.00MP/S0.76EPS this Y61.60%Inst Trans-Short Ratio4.45Perf Half Y18.32%
Sales13.38BP/B2.11EPS next Y10.45%ROA3.49%Short Interest6.53MPerf YTD17.90%
Book/sh42.33P/C73.56EPS next 5Y7.85%ROE11.86%52W High92.18 -3.33%Perf Year31.08%
Cash/sh1.21P/FCF22.66EPS past 3/5Y-5.78% 3.15%ROIC6.24%52W Low61.95 43.84%Perf 3Y11.85%
Dividend Est.-EV/EBITDA13.66Sales past 3/5Y1.40% 5.43%Gross Margin29.69%Volatility3.00% 2.43%Perf 5Y13.27%
Dividend TTM-EV/Sales1.02EPS Y/Y TTM8.52%Oper. Margin5.60%ATR (14)2.20Perf 10Y26.36%
Dividend Ex-Date-Quick Ratio0.75Sales Y/Y TTM5.61%Profit Margin2.95%RSI (14)66.64Recom2.64
Dividend Gr. 3/5Y-Current Ratio1.36EPS Q/Q14.78%SMA203.80%Beta0.80Target Price87.63
Payout0.00%Debt/Eq0.77Sales Q/Q6.31%SMA508.18%Rel Volume2.17Prev Close86.51
Employees25,000LT Debt/Eq0.59EarningsNov 03SMA20016.45%Avg Volume1.54MPrice89.11
IPO DateNov 03, 1995Option/ShortYes / YesEPS/Sales Surpr.8.38% 0.77%Net Debt/EBITDA3.60Volume3,325,866Change3.01%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-28-26ReiteratedUBSNeutral$85$89
Jul-08-26InitiatedBMO CapitalMarket Perform$85
Jun-11-26UpgradeBTIGNeutralBuy$100
May-06-26ReiteratedRobert W. Baird$104$97
May-06-26ReiteratedMizuhoNeutral$81$82
May-06-26ReiteratedUBSNeutral$85
Apr-24-26ReiteratedMorgan StanleyUnderweight$64
Feb-25-26ReiteratedBarrington ResearchOutperform$79$97
Feb-24-26ReiteratedLeerink PartnersMarket Perform$75$87
Feb-23-26ReiteratedRobert W. Baird$92$100
Latest News
Aug-04-26
Jul-30-26
Jul-30-2607:00AM
Jul-28-26
Jul-24-26
Jul-23-26
Jul-21-26
Jul-20-26
Company

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/27/2025
FY 2024
12/28/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue13,38413,18412,67312,33912,64712,40110,1199,98613,202
Cost of Goods Sold Incl. D&A9,4109,3428,9088,6888,9988,7297,3056,8956,507
Gross Profit3,9743,8423,7653,6513,6493,6722,8143,0912,911
Selling, General and Administrative Excl. Other3,1463,0843,0362,9372,7112,8172,2472,3582,217
Research and Development
000000000
Other Operating Expense
7900000000
Operating Income749758729714938855567733693
Interest Expense154150131874428415176
Unusual Expense
Non-Operating Income (Expense)-48-63-72-71-15823-1416-60
Net Income Before Taxes547545526556736851512698558
Income Taxes12912612812017019795160107
Consolidated Net Income395398390416538624402508536
Net Income From Continuing Operations418419398436566653417539450
Net Income395398390416538624402508536
EPS (Recurring)3.343.293.073.183.954.512.823.443.51
EPS (Basic, Before Extraordinaries)3.343.293.073.183.954.512.823.443.51
EPS (Diluted)3.313.273.053.163.914.452.803.403.49
EBITDA1,0021,0069418779771,068727916756
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio26.9223.2823.0923.9620.4317.4223.8819.6217.65
Price To Sales Ratio0.770.700.710.800.860.880.940.990.71
Gross Margin29.6929.1429.7129.5928.8529.6127.8130.9522.05
Operating Margin5.605.755.755.797.426.895.607.345.25
Net Margin2.953.023.083.374.255.033.975.094.06
Shares Outstanding115121127131136140143148153
Market Capitalization10,2489,2128,9439,91810,86210,8549,5619,8759,422
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$93.17$84.37$75.57$66.77$57.97 Close Price0.00M1.15M2.30M3.44M4.59MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
DANIEL WILLIAM KDirectorMay 11 '26Buy69.1910,000691,90020,000May 12
Popeck Thomas CCEO, Henry Schein ProductsMar 19 '26Sale72.791,35598,63086,182Mar 20
KUEHN KURT PDirectorMar 10 '26Sale78.962,844224,56515,420Mar 11
LASKAWY PHILIP ADirectorMar 05 '26Sale80.362,844228,54421,961Mar 06
MLOTEK MARK EEVP, Chief Strategic OfficerMar 04 '26Sale80.805,925478,74080,554Mar 06
BERGMAN STANLEY MChairman, CEOMar 02 '26Sale81.3143,8123,562,354383,803Mar 03
BERGMAN STANLEY MChairman, CEOFeb 27 '26Sale81.2010,785875,742309,092Feb 27
BERGMAN STANLEY MChairman, CEOFeb 26 '26Sale81.0138,3463,106,591427,615Feb 27
DANIEL WILLIAM KDirectorAug 07 '25Buy67.0810,000670,80010,000Aug 11
LASKAWY PHILIP ADirectorMar 19 '25Sale71.042,604184,99924,805Mar 20
Connett Bradford CCEO, NA Distribution GroupMar 19 '25Sale71.154,036287,16162,688Mar 20
KUEHN KURT PDirectorMar 05 '25Sale71.552,787199,39615,687Mar 06
Ettinger Michael SEVP & Chief Operating OfficerNov 18 '24Sale75.0012,240918,00087,706Nov 20
McGlynn LoreleiSVP, Chief Human Res. OfficerSep 06 '24Sale69.3021,0351,457,72671,833Sep 09
MLOTEK MARK EEVP, Chief Strategic OfficerAug 14 '24Sale69.123,000207,36087,851Aug 15
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.